VIATRIS INC. for VIATRIS INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
| ANNE WILSON | — |
Copyright/Patent/Trademark CPT
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
| ANNE WILSON | — |
Trade (domestic/foreign) TRD
Trade issues related to generic medicines Pharmaceutical supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
Financial Institutions/Investments/Securities FIN
Policy related to corporate governance
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID MARIN | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.